Single- or Multi-Fraction SABR for Lung Oligometastases?
Both single-fraction and multifraction stereotactic ablative body radiotherapy (SABR) had acceptable safety and comparable efficacy for patients with pulmonary oligometastases, according to results from a phase II randomized trial. The primary endpoint of grade 3 or higher adverse events (AEs) related to treatment within 1 year of SABR was similar between the single-fraction arm (5%) […]